Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-03

FDA Approved: DEPO-ESTRADIOL — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

FDA approved a supplemental application for Depo-Estradiol (estradiol cypionate) by Pharmacia & Upjohn Company LLC under ANDA085470.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEPO-ESTRADIOL (Estradiol cypionate)

Snippet

SUPPL AP for DEPO-ESTRADIOL (ESTRADIOL CYPIONATE)